ARTICLE | Company News
Regulus, Sanofi deal
July 1, 2013 7:00 AM UTC
Last week, Regulus disclosed that on June 21 it granted Sanofi an exclusive option to license co-development and commercialization rights to undisclosed microRNA targets and biomarkers. Sanofi agreed ...